TrialNature communications2025

Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma.

Courtney L Gaberino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.